Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
08/2002
08/14/2002CN1364073A Skin care composition for mediating cell to cell communication
08/14/2002CN1363681A Activated lymphocyte from umbilical cord blood, preparations containing it as main content and method therefor
08/14/2002CN1363393A Process for preparing health-care compound sheep placenta extract food series
08/14/2002CN1363387A Exterior-applied medicine for treating hyperosteogeny and lumbar intervertebral disk protrusion
08/14/2002CN1363375A Medicinal composition for relaxing chronic renal failure
08/14/2002CN1363366A Antivirus defervescent
08/14/2002CN1363358A Chinese-medicinal ointment for treating burn and scald and its preparing process
08/14/2002CN1363353A Medicine for treating ophthalmopathy
08/14/2002CN1363318A Capsule 'Jingmaitong'
08/14/2002CN1363314A Medicine for treating renal calculus and its preparing process
08/14/2002CN1363284A Process for brewing biological intensified medical honey
08/14/2002CN1363283A Beetoxin injection and its preparing process
08/14/2002CN1363282A Multifunctional 'Baikuang Kangti Powder'
08/14/2002CN1089003C Yang Strengthening importance-eliminating decoction
08/14/2002CN1089002C Chinese patent medicine for treating oral ulcer and Baiser's disease
08/14/2002CN1088997C Chinese-medical oral liquid for treating cerebral diseases caused by hypertension and its preparing process
08/14/2002CN1088995C Process for producing free-dried powder of sheep embryo by vacuum freezing
08/13/2002US6432929 Cartilage enhancing food supplements and methods of preparing the same
08/13/2002US6432927 Compositions and methods for inducing gene expression
08/13/2002US6432918 Methods and compositions for optimization of oxygen transport by cell-free systems
08/13/2002US6432714 Reducing viral loads in hiv positive subjects and killing cells
08/13/2002US6432710 Regenerating tissue that deteriorated
08/13/2002US6432709 Encapsidation cell lines and expression vectors for transcomplementation of defective retroviral vectors
08/13/2002US6432707 Isolation of polynucleootide
08/13/2002US6432700 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same
08/13/2002US6432653 Separation of cells from lymphs or myeloid linage with bonding and contacting cells
08/13/2002US6432435 Crosslinked thin films or sheets for use as grafting and wound healing agents; nontoxic and nonantigenic
08/13/2002US6432399 Treatment of stress and preconditioning against stress
08/13/2002US6432398 Methods of treating diseased cells
08/13/2002CA2127987C Pharmaceutical bacteriocin compositions
08/13/2002CA2080830C Decontaminated biological material
08/08/2002WO2002061424A2 Organ system microarrays
08/08/2002WO2002061420A2 Vitro in a cell interaction culture system for testing and developing medicaments
08/08/2002WO2002061105A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
08/08/2002WO2002061053A1 Renal stem cells and uses thereof
08/08/2002WO2002061052A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
08/08/2002WO2002061040A2 Gene delivery formulations and methods for treatment of ischemic conditions
08/08/2002WO2002061033A2 Transfection of human embryonic stem cells
08/08/2002WO2002060950A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
08/08/2002WO2002060932A2 A serpin in bifidobacteria
08/08/2002WO2002060931A2 A fimbria-like gene in bifidobacteria
08/08/2002WO2002060928A2 Medane genes and proteins
08/08/2002WO2002060475A1 Methods for stabilizing lyophilized blood proteins
08/08/2002WO2002060461A1 Blood brain barrier modulation using stressed autologous blood cells
08/08/2002WO2002060413A1 Implantable bioartificial active secretion system
08/08/2002WO2002060396A2 Hair follicle neogenesis by injection of follicle progenitor cells
08/08/2002WO2002060376A2 Induction of tolerance by apoptotic and/or necrotic cells
08/08/2002WO2002060279A1 $g(a)-lactalbumin as prebiotic agent
08/08/2002WO2002060276A1 Combination of probiotics
08/08/2002WO2002060252A1 Rabbit sperm diluent and an artificial insemination method using said diluent
08/08/2002WO2002060234A2 Herbal composition for treatment of neuronal injuries and neuronal degeneration, methods to prepare the same and uses thereof
08/08/2002WO2002034903A3 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications
08/08/2002WO2002028165A3 Compositions and methods of using capsid protein from flaviviruses and pestiviruses
08/08/2002WO2002022175A3 Method and composition for treating tumors by selective induction of apoptosis
08/08/2002WO2002020762A3 Tnf receptor-like molecules and uses thereof
08/08/2002WO2002018432A3 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport
08/08/2002WO2002007742A3 Bacteriophage having multiple host range
08/08/2002WO2002007679A3 Adult human dental pulp stem cells in vitro and in vivo
08/08/2002WO2001096393A3 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
08/08/2002WO2001095917A3 Kefir extract as an anti-cancer agent
08/08/2002WO2001092547A3 Modified bovine adenovirus having altered tropism
08/08/2002WO2001087935A3 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
08/08/2002WO2001016330A3 Prevention of affections associated with porcine circovirus-2
08/08/2002WO2001013714A3 Prostatic cell line and animal model of a prostatic tumor
08/08/2002WO2001009325A9 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations
08/08/2002US20020107869 Novel implant and novel vector for the treatment of acquired diseases
08/08/2002US20020107363 B7-Like molecules and uses thereof
08/08/2002US20020107330 Drug delivery compositions and medical devices containing block copolymer
08/08/2002US20020107292 Primary composition comprising a lipophilic bioactive compound
08/08/2002US20020107225 Use of nucleoside analogues (cytosine or 5-fluorocytosine containing compound) useful for acute or chronic myelogenous leukemia
08/08/2002US20020107213 Gene therapy of alzheimer's disease by delivery of an encoded apoliprotein E
08/08/2002US20020107210 Compositions and methods for the treatment of autoimmune diabetes
08/08/2002US20020107205 Exposing to a matrix of type I collagen and bone morphogenic protein-4 (BMP-4)
08/08/2002US20020106798 Plasmid for use in vaccination of animals aganist fungal, bacterial and viral infections
08/08/2002US20020106746 Nucleotide sequences coding preferential protein for use in the treatment of septic shock, liver and immunological, tumors and connective tissue defects
08/08/2002US20020106731 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of apoptosis and inflammation defects
08/08/2002US20020106703 Screening cell pool for pancreatic progenitor cells; obtain mammalian cell culture, incubate with marker protein, detect those cells bound by marker protein
08/08/2002US20020106631 Recombinant, active caspases and uses thereof
08/08/2002US20020106625 Apparatus for use in the generation of bone tissues
08/08/2002US20020106353 Donor tissue is harvested, subjected to a cell dissociation treatment, cells suitable for grafting back to a patient are collected and dispersed in a solution that is suitable for immediate dispersion over recipient graft site
08/08/2002US20020106352 Introducing cartilage producing cells into the skin contour irregularity thereby effecting cosmetic repair thereof
08/08/2002US20020106349 Dilute viral suspension is prepared corresponding to the dilution of a viral suspension in an aqueous solution containing salt or hexose; dilute viral suspension is nebulized pressurized gas of or an ultrasound frequency
08/08/2002CA2436343A1 Blood brain barrier modulation using stressed autologous blood cells
08/08/2002CA2436281A1 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
08/08/2002CA2435709A1 Hair follicle neogenesis by injection of follicle progenitor cells
08/08/2002CA2434281A1 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
08/08/2002CA2430653A1 Transfection of human embryonic stem cells
08/08/2002CA2428655A1 Herbal composition for treatment of neuronal injuries and neuronal degeneration, methods to prepare the same and uses thereof
08/08/2002CA2426582A1 Gene delivery formulations and methods for treatment of ischemic conditions
08/07/2002EP1229124A1 Nucleic acid transporter containing polypeptide and recombinant virus vector
08/07/2002EP1228769A1 Symbiotic regenerative composition
08/07/2002EP1228708A2 Milk derived basic protein fraction as agents for improving lipid metabolism and reducing high blood pressure
08/07/2002EP1228707A1 Use of alpha-lactalbumin as prebiotic agent
08/07/2002EP1228373A2 Diagnosis and therapy of cancer using sgp28-related molecules
08/07/2002EP1228234A2 Production of chimeric capsid vectors
08/07/2002EP1228232A2 Recombinant sendai virus vector for introducing exogenous genes to airway epithelia
08/07/2002EP1228212A2 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof
08/07/2002EP1228208A2 36p6d5: secreted tumor antigen
08/07/2002EP1228202A2 Antisense compositions and cancer-treatment methods
08/07/2002EP1228195A1 Cultures of gfap?+ nestin?+ cells that differentiate to neurons